ZIC2 and nasopharyngeal carcinoma: Additionally, Yu et al. (2020) demonstrate that miR-129-5p overexpression silences ZIC2 and decreases NPC cell proliferation, migration, and invasiveness, suggesting that miR-129-5p may serve as a novel therapeutic tool for NPC.